Key statistics
On Friday, Monopar Therapeutics Inc (MNPR:NAQ) closed at 20.10, -47.79% below its 52-week high of 38.50, set on Oct 24, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 19.88 |
---|---|
High | 20.21 |
Low | 19.54 |
Bid | 19.50 |
Offer | 21.00 |
Previous close | 19.71 |
Average volume | 112.99k |
---|---|
Shares outstanding | 5.28m |
Free float | 3.01m |
P/E (TTM) | -- |
Market cap | 104.03m USD |
EPS (TTM) | -1.99 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 21:00 GMT.
More ▼
- Monopar Therapeutics Reports Third Quarter 2024 Financial Results and Recent Developments
- Monopar Therapeutics Inc. Announces Closing of $19.2 Million Public Offering of Common Stock
- Monopar Therapeutics Inc. Announces Pricing of $19.2 Million Public Offering of Common Stock
- Monopar Therapeutics Inc. Announces Proposed Public Offering of Common Stock
- Monopar Announces Agreement with Alexion, AstraZeneca Rare Disease For Late-Stage Wilson Disease Drug Candidate
- Monopar Presents Encouraging Human Clinical Dosimetry Data on its uPAR Program at EANM 2024
- Monopar Expands Radiopharma Intellectual Property Portfolio with Patent Filing on New Compounds and Linkers
- Monopar Initiates Clinical Trial of Novel uPAR-Targeted Radiopharmaceutical Therapy in Advanced Cancers
- Monopar Announces Positive Early Human Clinical Data Validating the Tumor Targeting Ability of MNPR-101-Zr
- Monopar to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
More ▼